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Abstract
A novel porcine gammaherpesvirus was detected in the blood of domestic pigs by PCR. With degenerate-primer PCR and subsequent
long-distance PCR approaches a 60-kbp genome stretch was amplified. Sequence analysis revealed the presence of the gammaherpesvirus
ORFs 03 to 46 as well as a putative chemokine receptor and a v-bcl-2 gene. The 60-kbp sequence was compared with the corresponding
sequence of the porcine lymphotropic herpesvirus 1 (PLHV-1) published recently and the sequence of PLHV-2, which was amplified from
porcine tonsil. Considerable sequence differences (amino acid identities: 49–89%) were found between the novel virus and PLHV-1 as well
as PLHV-2, which were very closely related to each other (amino acid identities: 85–98%). The novel virus had essentially the same genome
organization as PLHV-1 and -2 and was therefore designated PLHV-3. Like PLHV-1 and -2, PLHV-3 was frequently found in the blood
and in lymphoid organs of domestic and feral pigs from different geographic locations. In the blood, the PLHVs were detected
predominantly in B-cells. Indication for latent as well as productive PLHV-3 infection was found in the porcine B-cell line L23. It can be
concluded that the PLHVs are widespread and are likely to cause a persistent B-lymphotropic infection. Since PLHV-1 has been implicated
in the development of porcine posttransplantation lymphoproliferative disease, all porcine lymphotropic gammaherpesviruses are of concern
when pigs are used as donors in xenotransplantation.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
In xenotransplantation, the absence of potentially patho-
genic viruses in donor animals is an important safety issue.
Since pigs are currently favored as donors of xenografts
(Auchincloss and Sachs, 1998; O’Connell et al., 2000),
attempts were undertaken to define the porcine viruses of
concern and to breed pigs free of these viruses. Previously
unknown porcine viruses were identified and a character-
ization of their biological properties was initiated (Iverson
and Talbot, 1998; Meng et al., 1998; Onions et al., 2000;
Patience et al., 1997).
We recently reported the discovery of DNA sequences of
two closely related gammaherpesviruses in pigs—the por-
cine lymphotropic herpesviruses 1 and 2 (PLHV-1 and -2).
These viruses are widespread in domestic pigs and are
closely related to several ruminant gammaherpesviruses,
most of which are etiologically implicated in the occurrence
of malignant catarrhal fever (MCF), a lymphoproliferative
and inflammatory disease with an often fatal outcome.
PLHV-1 and -2 are also related to EBV, HHV-8, and other
gammaherpesviruses, but more distantly (Ehlers et al.,
1999b; Ulrich et al., 1999).
In allotransplantation, EBV is etiologically involved in a
posttransplantation lymphoproliferative disease (PTLD)
which represents a spectrum of lymphoid proliferations
ranging from a reactive polymorphic expansion of EBV-
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infected lymphocytes to monoclonal B-cell lymphomas
(Ferry and Harris, 1994). Evidence for a similar pathogenic
potential of PLHV-1 was reported by Huang et al. (2001).
Immunosuppressed miniature swine were subjected to allo-
geneic hematopoietic stem cell transplantation. Under these
conditions, a high incidence of a syndrome very similar to
human PTLD was observed, with most of the diseased
animals dying. In the blood and lymph nodes, high amounts
of a porcine gammaherpesvirus were detected by PCR. This
was later found to be identical to PLHV-1. Furthermore,
early and late genes of PLHV-1 were found to be tran-
scribed in PTLD-affected pigs (Goltz et al., 2002). Thus,
safe xenotransplantation with organs of swine requires the
generation of pigs, which are both free of these and any
other related porcine herpesviruses in order to minimize
virus-related risks for transplanted patients.
The aim of the present study was therefore to search for
unknown herpesviruses in porcine blood and tissues. A
pan-herpes consensus PCR assay was used which targets a
highly conserved region of the herpesviral DNA polymerase
(DPOL) gene (Ehlers et al., 1999a). This approach had
already enabled the discovery of PLHV-1 and PLHV-2 and
other vertebrate herpesviruses (Chmielewicz et al., 2001;
Ehlers et al., 1999a; 2001). Application of this assay to
porcine blood and tissue samples resulted in the detection of
a novel DPOL sequence indicating the presence of a previ-
ously unknown gammaherpesvirus. Here we present the
characterization of a 60-kbp sequence of this novel virus
and compare it with the corresponding sequences of
PLHV-1 and PLHV-2, the latter being also determined in
this study. Furthermore, we report on the analysis of PLHV
prevalences in pigs, demonstrate the presence of the PLHVs
in peripheral B-lymphocytes, and present evidence for
PLHV-3 infection in a permanent porcine B-cell line.
Results
Detection of a novel porcine herpesvirus with pan-herpes
PCR
A pan-herpes PCR assay targeting conserved regions of
the herpesvirus DPOL gene was used to search for unknown
gammaherpesvirus species in pigs. Since PLHV-1 and
PLHV-2 have a high prevalence in domestic and feral pigs
(Ehlers et al., 1999ab; Ulrich et al., 1999), we only screened
blood and tissue samples free of PLHV-1 and PLHV-2
sequences. In the blood of a German domestic pig (sample
no. 1412) a novel gammaherpesvirus-like DPOL sequence
was detected which exhibited only 66% identity to the
corresponding DPOL sequences of PLHV-1 and PLHV-2
and less than 60% to all other known gammaherpesviruses.
The putative virus, from which the novel sequence origi-
nated, was tentatively designated “porcine lymphotropic
herpesvirus 3” (PLHV-3). A search for other PLHV-3-
positive samples using a specific PCR revealed a spleen
sample (no. 489) which contained a higher copy number
than the blood sample no. 1412. This was therefore used for
determining the sequence of a genome stretch of PLHV-3.
Amplification and sequence analysis of 60 kbp of the
PLHV-3 genome
A PCR-based approach was chosen because neither a
lytical cell culture system nor a permanent cell line with
sufficient copies of PLHV-3 was available at the beginning
of this study. Initially, pan-gammaherpesvirus PCR assays
were used to generate partial sequences of conserved genes
(ORFs 03, 06, 08, 17, 25, 39, 44, and 46). The common
block organization of the conserved gammaherpesvirus
genes (for an overview, see Schulz, 1998; Simas and Efsta-
thiou, 1998) enabled us then to amplify the interspersed
sequences with PLHV-3-specific primers and long-distance
PCR. Nine overlapping fragments of 3-12 kbp length were
generated (Fig. 1a) and sequenced by primer walking. The
5-part of ORF 03 was determined by genome walking (see
Methods). A final 60326-bp sequence was generated, ex-
tending from the 5-noncoding region of ORF 03 into ORF
46. It was verified with 616 overlapping PCR fragments
resulting in an average redundancy of 5. The sequence has
a GC content of 39% and reveals a strong suppression of
the CpG dinucleotide frequency.
Gene arrangement of PLHV-3
The PLHV-3 sequence determined includes the first and
a major part of the second conserved gene block of the
gammaherpesvirus subfamily. Upstream of the first gene
block, an ORF coding for a viral phosphoribosylformylgly-
cineamide amidotransferase (FGARAT; ORF 03) was
found. Within the gene block, the major DNA-binding pro-
tein (ORF 06), a transport protein (ORF 07), the glycopro-
tein B (gB; ORF 08), the DNA polymerase (ORF 09), and
two conserved ORFs with unknown function (ORFs 10 and
11) were identified. Interspersed between these were two
ORFs which were not conserved among the gammaherpes-
viruses, E4/BALF1h and A5/BILF1h (Fig. 1a; Table 1). The
ORF E4/BALF1h is homologous to genes which are at the
same genomic position in EHV-2 (ORF E4), EBV (ORF
BALF1), and two monkey lymphocryptoviruses, CeHV-15
(ORF BALF1) and CaIHV-3 (ORF 01). BALF1 was re-
ported to be a viral homolog of the mammalian bcl-2 on-
cogene (v-bcl-2), which encodes a functional apoptosis in-
hibitor (Marshall et al., 1999). The ORF A5/BILF1h is
related to the ORFs A5 of A1HV-1, E6 of EHV-2, BILF1 of
EBV, and CeHV-15 as well as ORF 06 of CalHV-3. No
homologs are present in other rhadinoviruses. The encoded
proteins have seven hydrophobic domains and may repre-
sent herpesviral G-protein-coupled receptors (McGeoch,
2001; Goltz et al., 2002). Within the second conserved gene
block, genes encoding the thymidine kinase (TK, ORF 21),
the glycoprotein H (gH, ORF 22), the major capsid protein
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(MCP, ORF 25), the terminase (ORFs 29a,b), the glyco-
protein M (gM, ORF 39), and the helicase (ORF 44) as well
as an immediate early gene (ORF 45) and part of the
uracil-DNA-glycosidase gene (ORF 46) were identified
(Fig. 1a; Table 1).
Upstream of ORF 03 and between the ORFs 11 and 17,
four short ORFs were found which did not match signifi-
cantly in database searches and did not reveal counterparts
in PLHV-1 and PLHV-2 (Fig. 1b).
PLHV-3 is a distant member of the PLHV group
The 60-kbp sequence of PLHV-3 was compared with the
corresponding sequences of PLHV-1, PLHV-2, and other
gammaherpesviruses. For this purpose, the 60-kbp sequence
of PLHV-2 also had to be determined, since only 4.1 kbp
had been sequenced previously (Ulrich et al., 1999). This
was done by amplification from DNA of a PLHV-2-posi-
tive, PLHV-1- and PLHV-3-negative tonsil sample (no.
568) of a German feral pig as described under Methods. A
73-kbp PLHV-1 sequence had been determined earlier from
DNA of a Spanish domestic pig (Goltz et al., 2002). In
Table 1, the potential PLHV-3 genes and their homologs in
PLHV-1, PLHV-2, A1HV-1 (the most closely related non-
porcine rhadinovirus), and HHV-8 and in the lymphocryp-
tovirus EBV are listed.
The gene organization of PLHV-3 is identical to that of
PLHV-1 and -2 in the analyzed region of the genome. This
applies not only to the conserved herpesvirus ORFs but also
to the gammaherpesvirus-specific ORFs 03, 10, 11, 23, and
27, as well as for the nonconserved ORFs E4/BALF1h and
A5/BILF1h (Table 1). However, the amino acid identity
values of 49–89% between PLHV-3 and PLHV-1 or
PLHV-2 clearly show that PLHV-3 is far more distantly
related to PLHV-1 and PLHV-2 than these two viruses are
to each other (85–98%; Table 1). The amino acid identity
Fig. 1. Map of the open reading frames of the 60-kbp sequence of PLHV-3. (a) ORFs are shown as arrows. Description of ORFs and abbreviations are given
in Table 1 (E4  E4/BALF1h; A5  A5/BILF1h). Black arrows indicate ORFs found in two or all three subfamilies of the herpesviruses. Open arrows
symbolize ORFs described only for gammaherpesviruses. Black lines, designated A to I, symbolize the amplimers generated with long-distance PCR which
demonstrate the contiguity of the PLHV-3 sequence. The dashed arrow symbolizes a PCR amplimer generated by genome walking. A scale in kbp is given
above. Base 1 is the first base of the genome stretch determined in this study. This position is not identical with the beginning of the long unique region of
PLHV-3, which has not yet been determined. (b) The two genome regions coding for ORFs, which are not conserved among the PLHVs and are not found
in other herpesviruses, are shown enlarged. Scale and symbols for conserved ORFs refer to part (a) of the figure. The position and orientation of the
non-conserved ORFs are symbolized by gray arrows. For PLHV-2, sequence information upstream of ORF 03 is not available (n.a.), as indicated.
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values between PLHV-3 and other gammaherpesviruses are
less than 67%, as exemplified by comparison with A1HV-1,
HHV-8 and EBV (Table 1).
Phylogenetic analysis was based on amino acid sequence
alignments which were performed with a set of conserved
genes (ORFs 06, 08, 09, 29, and 44). The five alignments
were concatenated, regions with gaps were removed and the
resulting composite alignment (3788 aa) was analyzed with
the neighbor/joining method. The phylogenetic tree showed
branching of PLHV-3 with the PLHV-1/PLHV-2 pair and,
more distantly, with AIHV-1. This was confirmed with
parsimonial analysis (program Protpars) and with analyses
Table 1
Potential PLHV-3 ORFs and homologs to PLHV-1, PLHV-2, AIHV-1, HHV-8, and EBV
PLHV PLHV-3
Size (aa)
PLHV-1 PLHV-2 PHLV-1/
PLHV-2
%id
AIHV-1 HHV-8 EBV Description
ORF Pol %id size %id size %id size %id size %id size ORF
P1.1  — — 107 n.a. — — — — — — —
P3.1  73 — — n.a. — — — — — — —
P3.2  97 — — n.a. — — — — — — —
03a  1378 69.5 1378 69.7 1376 90.6 32.5 1369 — — — — — Phosphoribosylformylglycineamide
amidotransferase (v-FGARAT)
E4/BALF1  219 81.9 178 82.6 178 92.1 — — — — 22.3 220 BALF1 v-bcl-2
06  1125 80.5 1126 80.2 1142 95.9 56.9 1127 48.7 1133 44.0 1128 BALF2 Major DNA-binding protein (MDBP)
07  674 73.8 675 73.1 674 91.2 50.0 680 43.0 695 38.2 789 BALF3 Transport protein
08  876 77.5 876 78.1 876 93.4 56.8 854 45.7 845 44.9 857 BALF4 Glycoprotein B (gB)
09  1001 80.1 1004 79.7 1001 95.1 63.1 1026 57.6 1012 53.2 1015 BALF5 DNA polymerase (DPOL)
A5/BILF1  338 61.3 325 63.7 304 89.5 31.1 302 — — 22.0 312 BILF1 G-protein-coupled receptor (v-GCR)
10  400 59.6 401 60.6 417 90.3 26.6 404 20.7 418 b 422 RAJILF1
11  410 63.8 409 63.4 409 89.5 41.8 406 26.2 408 31.8 429 RAJILF2
P1.2  — — 77 — — — — — — — — — —
P3.3  71 — — — — — — — — — — — —
P1.3  — — 78 — — — — — — — — — —
P2.1  — — — — 80 — — — — — — — —
P1.4  — — 69 — — — — — — — — — —
P3.4  68 — — — — — — — — — — — —
17  527 66.1 500 65.2 500 91.4 45.1 524 43.2 553 35.3 605 BVRF2 Capsid protein
18  258 72.6 261 74.5 261 91.6 44.9 275 41.5 257 — — —
19  555 71.7 549 71.0 549 91.6 50.7 556 41.4 549 36.5 570 BVRF1 Tegument protein
20  254 71.8 275 73.8 232 93.1 39.5 250 42.2 320 32.4 248 BXRF1
21  574 71.7 580 71.3 578 86.7 36.1 561 30.6 580 37.5 607 BXLF1 Thymidin kinase (TK)
22  772 68.9 778 69.5 778 90.6 36.6 733 27.0 730 28.5 706 BXLF2 Glycoprotein H (gH)
23  412 75.5 398 73.4 399 91.5 43.9 401 31.3 404 33.3 425 BTRF1
24  734 73.3 736 72.5 736 91.2 51.3 745 42.4 752 41.8 575 BcRF1
25  1376 88.5 1372 88.3 1372 97.7 67.3 1370 57.4 1376 55.1 1381 BcLF1 Major capsid protein (MCP)
26  304 82.9 304 83.3 304 97.7 60.6 306 47.5 305 49.2 301 BDLF1 Capsid protein
27  310 69.1 294 70.2 294 90.5 41.5 292 29.0 290 20.7 420 BDLF2
29  684 80.5 683 81.0 683 96.0 62.1 686 54.4 687 51.6 690 BDRF1 Cleavage/packaging protein
30  80 49.4 79 50.6 91 84.8 30.0 85 30.0 78 21.9 77 BDLF3.5
31  214 72.8 206 73.4 206 95.6 41.6 225 38.6 224 36.7 225 BDLF4
32  455 62.7 453 60.4 453 89.8 35.9 474 27.4 454 22.2 507 BGLF1 DNA cleavage/packaging protein
33  339 85.8 339 85.5 347 96.2 45.4 335 32.7 312 45.6 336 BGLF2
34  324 73.1 326 73.5 326 93.9 46.8 343 37.1 327 34.2 332 BGLF3
35  146 61.6 151 61.9 151 93.4 34.0 152 26.0 150 26.2 153 BGLF3.5
36  454 75.1 453 74.2 453 95.6 42.8 454 27.3 444 29.0 455 BGLF4 Kinase (PK)
37  485 87.6 485 91.1 485 97.6 62.1 485 42.9 486 45.7 470 BGLF5 Alkaline exonuclease
38  61 80.6 63 83.9 63 92.1 41.4 59 27.1 61 37.1 75 BBLF1
39  382 79.1 378 78.4 378 93.4 65.2 374 44.9 400 49.9 405 BBRF3 Glycoprotein M (gM)
40  449 52.8 455 51.7 467 85.9 30.8 478 26.8 457 23.6 522 BBLF2 Helicase-primase complex component
41  180 54.9 162 55.8 162 89.5 24.9 175 25.9 205 35.3 201 BBLF3 Helicase-primase complex component
42  267 78.2 266 79.0 266 89.9 44.9 257 36.0 278 37.5 278 BBRF2
43  567 80.6 567 80.7 566 95.2 62.7 557 54.9 605 48.8 613 BBRF1 Capsid protein
44  843 82.1 782 82.2 782 97.3 63.4 783 55.6 788 50.6 809 BBLF4 Helicase
45  178 63.3 223 60.4 223 89.7 38.3 235 30.1 407 27.0 217 BKRF4
Pol, polarity; ORF, orientation; %id, percentage amino acid identity to the corresponding PLHV-3 ORF; n.a., not available; for PLHV-2 no sequence
information upstream of ORF 03 is available.
a The nomenclature of the ORFs 03 to 45 is identical in PLHV-1, PLHV-2, PLHV-3, AIHV-1, and HHV-8.
b Identity value below 20%.
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of individual proteins with both algorithms (data not
shown). Phylogenetic analysis of DPOL and gB sequences
(684 aa), in which ruminant gammaherpesviruses could be
additionally included, placed the PLHVs similarly close to
AIHV-1, OvHV-2, BLHV, and CprHV-2. Collectively,
these seven viruses of artiodactyla form a separate clade
within the gammaherpesvirus tree (Fig. 2).
The PLHVs are widely distributed and genetically stable
To determine the prevalence of PLHV-3 in different
herds of commercial domestic pigs in Germany, PCR with
the primer pairs 886-S/886-AS (DPOL) and 905-S/905-AS
(gB) (Table 2) was performed. Peripheral blood leukocyte
(PBL) samples (n  92) from 16 different herds (5–9
pigs/herd) were tested, and 47 samples (51%) originating
from 14 herds were positive for PLHV-3 (Table 3). More
than 90% of the positive samples reacted in both PCR
assays which indicated that both assays had a very similar
sensitivity. For some of the amplimers the PLHV-3 origin
was controlled by sequence analysis.
Real-time PCR assays specific for PLHV-1, PLHV-2,
and PLHV-3 were also established (Table 2) and applied to
the same collection of blood samples, since the detection
limits had been determined to be less than 20 copies of viral
genome. The results for PLHV-3 (48%) were in agreement
with the data obtained by conventional PCR (51%).
PLHV-2 was found in 16% and PLHV-1 in 54% of the
samples (Table 3). The prevalence in lung (n  27) and
spleen (n  34) from German pigs was also tested with
Fig. 2. Phylogenetic relatedness of PLHV-3. A phylogenetic tree was constructed with the neighbor/joining method, using concatenated multiple amino acid
sequence alignments of conserved regions of gB and DPOL. The PLHV-3 and PLHV-2 amino acid sequences were deduced from the nucleotide sequences
determined in this study. Amino acid sequences of other gammaherpesviruses were obtained from GenBank (Accession Nos. under Methods). The bootstrap
values derived from 100 repetitions are indicated at the branching points of the tree. The upper values were obtained with neighbor/joining analysis, the lower
values with parsimonial analysis. A low bootstrap value was obtained at one node in the center of the tree and therefore not shown. Viruses classified to the
genus Rhadinovirus and to the genus Lymphocryptovirus are indicated as such. The PLHVs and several ruminant gammaherpesviruses form a separate clade
which is highlighted by gray background.
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real-time PCR. PLHV-1, -2, and -3 were found in 78, 41,
and 59% of the lung samples and in 59, 26, and 62% of the
spleen samples, respectively. In blood samples from 20
Italian domestic pigs, prevalences of 80, 20, and 65% were
found for PLHV-1, -2, and -3 respectively (Table 3). Of all
173 samples analyzed, 5 were positive for PLHV-1 and
PLHV-2, 46 for PLHV-1 and PLHV-3, and 11 for PLHV-2
and PLHV-3; 17 were positive for all three PLHVs. None of
the PLHVs were found in 23 samples.
PCR analysis of additional samples from domestic and
feral pigs from Germany, France, Spain, and the USA re-
vealed the presence of the three PLHV species in each of
these countries. For each PLHV species, six samples from
the different sources were investigated by sequence analysis
of 0.5 kbp of the gB gene to detect possible intraspecies
sequence differences. The gB region was chosen because it
is variable in different strains of some herpesvirus species
(Chou and Dennison, 1991; Lehner et al., 1991; Searles et
Table 3
Prevalence of the PLHV viruses
Tissue Farm Country N DPOL PCR
PLHV-3
gB PCR
PLHV-3
gB real-time-PCR
PLHV-3 PLHV-2 PLHV-1
Blood 1 Ger 5 2 2 2 2 4
Blood 2 Ger 6 2 2 2 0 6
Blood 3 Ger 6 3 3 3 1 1
Blood 4 Ger 5 4 5 5 1 4
Blood 5 Ger 7 7 6 6 1 4
Blood 6 Ger 6 2 3 2 0 5
Blood 7 Ger 5 3 3 3 0 3
Blood 8 Ger 5 5 4 4 2 5
Blood 9 Ger 5 1 1 0 0 3
Blood 10 Ger 5 5 5 5 3 2
Blood 11 Ger 5 2 2 2 1 3
Blood 12 Ger 5 3 3 3 0 1
Blood 13 Ger 5 4 3 4 1 3
Blood 14 Ger 8 4 5 3 2 0
Blood 15 Ger 5 0 0 0 1 0
Blood 16 Ger 9 0 0 0 0 6
 92 47 (51%) 47 (51%) 44 (48%) 15 (16%) 50 (54%)
Blood It 20 n.d. n.d. 13 (65%) 4 (20%) 16 (80%)
Lung Ger 27 n.d. n.d. 16 (59%) 11 (41%) 21 (78%)
Spleen Ger 34 n.d. n.d. 21 (62%) 9 (26%) 20 (59%)
Ger, Germany; I, Italy; n.d., not done; , sum.
Table 2
Primers
Primer name Gene Primer sequence Tann (°C)a
PLHV-3-specific primers for prevalence analyses
905s ORF08 (gB) 5-ACA AGA GCC TTA GGG TTC CAA ACT-3 57
905as ORF08 (gB) 5-GTG TCC AGT GTT GTA ATG GAT GCC-3
886s ORF09 (DPOL) 5-CAA GAT TGC TGA GAC GGT GAC TAC-3 57
886as ORF09 (DPOL) 5-AAA TGG CAT GGT TAC ATC TTT AGG-3
TaqMan primers and probes
1125s PLHV-1 gB 5-CTC ACC TCC AAA TAC AGC GA-3 55
1125as 5-GCT TGA ATC GTG TGT TCC ATA G-3
Probe 5-FAM-CTG GTC TAC TGA ATC GCC GCT AAC AG-TAMRA-3
1155s PLHV-2 gB 5-GTC ACC TGC AAA TAC ACA GG-3 55
1155as 5-GGC TTG AAT CGT ATG TTC CAT AT-3
Probe 5-FAM-CTG GTC TAC TGA AGC GCT GCC AAT AG-TAMRA-3
1156s PLHV-3 gB 5-AAG GAC CCC AAA GAG GAA A-3 55
1156as 5-CTG AGG CAC TGC ATA CTC TGT-3
Probe 5-FAM-TCA ATT TTA TGG TTC ACC TTC TAC CTT TCC T-TAMRA-3
468s -Actin 5-TCA CCC ACA CGG TGC CCA TCT ACG A-3 67
468as 5-CAC CGG AAG CGC TCG TTG CCG ATG G-3
Probe 5-FAM-ACG CCC TGC CCC ACG CCA TCC TGC GT-TAMRA-3
a Tann, annealing temperature; the values apply for the combination of the respective sense primer with the antisense primer below.
322 B. Chmielewicz et al. / Virology 308 (2003) 317–329
al., 1999). In addition, 0.4 kbp of the weakly conserved inter-
genic sequences between ORFs 11 and 17 were amplified and
sequenced. The variations found within each PLHV species
were below 0.1% for the gB gene and below 1% for the
intergenic region. A 25-kbp sequence of PLHV-3 (ORFs 03 to
17) was also determined from blood sample no. 1412. This
sequence and the corresponding region of the 60 kbp PLHV-3
sequence (spleen sample no. 489) differ by less than 0.1%.
Finally, the 60-kbp sequence of PLHV-2 (tonsil sample no.
568) was compared to a second PLHV-2 sequence of 32 kbp
length (tonsil sample no. 546). Differences below 0.1% were
observed (not shown). These data indicate that the PLHVs are
genetically stable, irrespective of their origin.
Presence of the PLHVs in PBMC subpopulations
To determine the cell types infected by the PLHVs in
porcine peripheral blood mononuclear cells, PBMCs were iso-
lated from 12 PLHV-positive pigs. They were incubated with
monoclonal antibodies specific for porcine B-, T-, or myeloid
cells (anti-immunoglobulin, anti-CD3, and anti-SWC3, respec-
tively), followed by an incubation with anti mouse IgG-Mi-
crobeads and purification of cells over a MACS column. The
resulting cell populations were analyzed with real-time PCR
for detection of PLHV-1, -2, or -3. Nine out of 12 animals
tested positive for PLHV-3, 2 for PLHV-2, and 9 for PLHV-1
in the unsorted PBMC samples (Fig. 3). The copy numbers of
viral DNA in the unfractionated PBMC were 1100–8104
(PLHV-3), 1.8101– 4,1101 (PLHV-2), and 1100–
2.8102 (PLHV-1) per 104 cells. Analysis of the subpopula-
tions showed a higher or at least similar copy number of viral
DNA in B-cells, compared with the unfractionated PBMCs
from 8 of 9 PLHV-3-infected, 4 of 9 PLHV-1-infected, and
both PLHV-2-infected animals. Copy numbers which were
comparable to those in the unsorted cells were also found in the
myeloid fractions from three pigs (one PLHV-3 and two
PLHV-1). Furthermore, the myeloid fraction from one of the
pigs, which tested positive for PLHV-1, was the only popula-
tion in which viral DNA was detectable. The T-cell fractions
were either completely negative or had only relatively low
copy numbers of viral DNA (Fig. 3). This detection of viral
DNA may be attributed to contamination of the T-cell fraction
with virus-carrying non-T-cells, although this cell population
always had a very high purity (98.9–99.8%). In 4 of 9 PLHV-1-
positive pigs all three cell fractions contained much lower
PLHV-1 copy numbers than the unfractionated PBMCs.
The sum of the copy numbers of the three subpopulations
was also much lower than that of the unsorted PBMCs of
these pigs. This indicates that a major part of the virus-
carrying cells was not targeted by the applied sorting con-
ditions.
Identification of PLHV-3 in a permanent porcine B-cell line
More than 20 permanent porcine cell lines—including
one of B-cell origin—were tested for the presence of PLHV
DNA with PCR. All cell lines were negative, with one
exception. The B-cell line L23 was found to contain the
PLHV-3 genome when tested with 14 PCRs of 3–6 kbp
length covering the complete 60-kbp sequence of PLHV-3
(not shown). With real-time PCR, approximately 400
Fig. 3. Presence of the PLHVs in PBMC subpopulations. B-cells, T-cells,
and myeloid cells were purified and tested with real-time PCR for the
presence of PLHV-1, PLHV-2, or PLHV-3 as described under Methods.
The relative DNA copy numbers of PLHV-1, -2, and -3 are shown for the
unsorted cells, the Ig cells, the CD3 cells, and the SWC3 cells of 12
pigs. In the unsorted cell samples the absolute copy numbers of viral DNA
were normalized to 100 and the copy numbers in the B-, T-, and myeloid
cell fractions calculated accordingly.
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PLHV-3 genome copies per cell were determined. Gardella
gel electrophoresis was performed to demonstrate genomes
complete PLHV-3 genomes in the L23 cell line. The
Gardella gel was blotted and hybridized with a mixture of
PLHV-3-specific probes. As a positive control, the EBV-
positive B95-8 cell line was hybridized with two EBV-
specific probes. The CD4 human cell line Molt 4, which
does not carry any herpesviruses, was used as a negative
control. As shown in Fig. 4, two hybridization signals were
seen in the B95-8 cell line. The more slowly migrating band
originates from episomal circular EBV genomes that are
associated with latent infection, while the fast migrating
band originated from linear EBV genomes packaged into
virus particles, as reported earlier (Gardella et al., 1984).
Analysis of the L23 cell line revealed one band migrating as
slowly as the episomal circular EBV genomes and a second
band migrating slightly faster than the linear EBV genomes.
This was confirmed in several independent experiments. It
indicated the presence of circular as well as linear PLHV-3
genomes in L23 cells.
Discussion
This study represents a firm identification of the third
porcine gammaherpesvirus species—PLHV-3—and its ini-
tial characterization. One of our goals was to perform a
comprehensive comparison of a sequence of the novel virus
with that of both PLHV-1 and PLHV-2 and was based on
genome stretches of 60 kbp. The results of amino acid
sequence comparisons of 37 homologous genes and of phy-
logenetic analyses clearly indicate that PLHV-3 forms a
group with PLHV-1 and PLHV-2 which is distinct from
other gammaherpesviruses. However, PLHV-3 is far more
distantly related to PLHV-1 and PLHV-2 than these two
viruses are to each other (Table 1, Fig. 2).
PLHV-3 exhibits, like PLHV-1 and PLHV-2, a high
intraspecies identity (99%). This is in accordance with a
previous analysis of the PLHV-1 and PLHV-2 DPOL loci
(Ehlers 1999a,b; Ulrich 1999) and the PLHV-1 gB-locus
(Goltz et al., 2002). It indicates that the PLHVs are genet-
ically stable viruses which may be perfectly adapted to their
natural host. It also ensures the conservation of the primer-
binding sites used in the PCR and real-time PCR assays.
An important observation is that the gene content of the
PLHVs is very similar to that of the wildebeest-associated
MCF virus AIHV-1, as shown for PLHV-3 and PLHV-2 in
this study and for PLHV-1 by Goltz et al. (2002). There is
also a close relationship to the sheep-associated MCF virus
OvHV-2, the bovine leukemia-associated BLHV, and the
recently described goat gammaherpesvirus CprHV-2, which
may be associated with a chronic disease syndrome of Sika
deer (Fig. 2; Ehlers et al., 1999a; Chmielewicz et al., 2001;
Li et al., 2001; Rovnak et al., 1998). Both AIHV-1 and
OvHV-2 are well adapted to their natural hosts, since they
are apathogenic in wildebeest and sheep. However, when
they infect foreign hosts like cattle or deer, they cause MCF,
a lymphoproliferative and inflammatory disease which is
fatal in most cases (Metzler, 1991; Plowright et al., 1960).
Recently, the potential of OvHV-2 to infect genetically
distant hosts was demonstrated when pigs became OvHV-2
infected and developed fatal MCF through contact with
OvHV-2-positive sheep (Loken et al., 1998; Albini, et al.,
2003). Both this and the recently reported association of
PLHV-1 with a lymphoproliferative disease in immunosup-
pressed, allotransplanted pigs (Goltz et al., 2002; Huang et
al., 2001) raise the concern that the PLHVs might cause a
similar lymphoproliferative syndrome in a pig-to-human
xenotransplantation.
According to the amino acid sequence comparisons (Ta-
ble 1) and phylogenetic analyses (Fig. 2), the partial ge-
nomes of the PLHVs have a gene content and arrangement
very similar to the ruminant rhadinovirus AIHV-1. In addi-
tion, the low GC content (40%) and the strong suppres-
sion of the CpG dinucleotide frequency are indicative for
rhadinoviruses (Ulrich et al., 1999). However, Goltz et al.
(2002) presented several lines of evidence that PLHV-1
may be closer related to the lymphocryptovirus EBV than to
Fig. 4. Gardella gel analysis of PLHV-3 in the porcine B-cell line L23.
PLHV-3-infected L23 cells (3  106) (Lane 1), 1  106 EBV-infected
B95-8 cells for positive control (Lane 2), and 5  106 Molt 4 cells for
negative control (Lane 3) were subjected to Gardella gel electrophoresis,
blotted, and hybridized to a mixture of all DIG-labeled probes as described
under Methods. Indicated by arrows are bands which represent circular and
linear viral genomes. The three parts of the figure originate from the same
blot and are a representative example of several experiments.
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other nonruminant rhadinoviruses. This may favor a divi-
sion of the genus Rhadinovirus into two genera. However,
the complete PLHV genome sequences have to be deter-
mined to enable a final classification.
In this study, experimental evidence for a B-cell tropism
of the PLHVs was obtained. The identification of PLHV-3
DNA in the permanent porcine B-cell line L23 demon-
strated the infection of this cell type. Circular and linear
genomes were detected by the Gardella technique (Fig. 4),
indicating latent and productive viral infection. In vivo, with
real-time PCR high PLHV DNA copy numbers were found
predominantly in the B-cell fraction and less frequently in
the myeloid fraction of PBMCs from 12 pigs. They were not
found in the T-cell fraction (Fig. 3). Interestingly, although
the B-cells appeared to be the main target cells for the
PLHVs, in the majority of the samples the viral copy num-
bers were only slightly higher or even lower as compared to
the unsorted control. This indicates that a major part of the
virus-carrying cells was not targeted by the applied sorting
conditions. One possible explanation might be the infection
of a cell type which was not targeted by the antibodies used
in this study. A possible candidate is the natural killer (NK)
cell, which has a CD3 phenotype in pigs (Yang and Park-
house, 1996) and was discussed as the proliferating cell type
in MCF of cattle (Swa et al., 2001). Presuming a tropism
mainly for B-cells, a second explanation could be the down-
regulation of IgM molecules on the cell surface caused by
the virus infection of the cell. Such a downregulation was
observed after expression of an HHV-8 protein (K1) in
BJAB-cells, an HHV-8-negative B-cell line. This protein
causes incorrect assembly of the IgM-containing B-cell an-
tigen receptor complex, which leads to a retention of the
complex in the endoplasmatic reticulum and therefore to a
lowered expression of IgM at the cell surface (Lee et al.,
2000). Such a lowered expression of the IgM molecule
would lead to a less efficient enrichment of the virus-
infected cells compared with the noninfected cells and result
in the moderate copy numbers found in our experiments.
However, it cannot be entirely ruled out that the binding
characteristics of the anti-immunoglobulin antibody were
the reason for the results obtained. The antibody was raised
against an IgG molecule, but recognizes all Ig subclasses (as
stated by the manufacturer). If this antibody had a different
affinity to the Ig subclasses and the maturation stages of B
cells also had different virus loads, then the obtained copy
numbers would give incomplete information. However, this
alone cannot fully explain the moderate levels of viral
genome copies in the B-cells. In summary, from the pre-
sented data it can be concluded that the B-cell is a major
target cell for PLHV infection in pigs. The presence of the
PLHVs in most compartments of the body can thus be
inferred and raises concern for the use of tissues and organs
in pig-to-human xenotransplantation.
PCR and real-time PCR analyses revealed that more than
80% of domestic pigs are infected with one or more PLHV
species (Table 3). This percentage even rose further to
90% when the samples included in this study were ana-
lyzed by PCR for the presence of the porcine cytomegalo-
virus (PCMV), a highly prevalent porcine betaherpesvirus
(Goltz et al., 2000; B. Ehlers and M. Goltz, unpublished
data). For several herpesviruses, including PCMV, intra-
uterine transmission has been reported (Edington et al.,
1977). There is also preliminary data indicating that this is
also the case for PLHV-1 (C. Patience, personal communi-
cation). Taking these considerations into account, elimina-
tion of herpesviruses from pigs by clean-catch procedures
using cesarean section or medicated early weaning (Alex-
ander et al., 1980) will be difficult. In addition, evaluation of
the PLHV status of live pigs by analysis of their blood may
give an underestimate as indicated by the higher prevalence
values found in organs as compared to blood samples (Table
3). Although comparative PCR analyses of organ and blood
samples from the same pigs are necessary to address this
question more precisely, these data indicate that the devel-
opment of reliable antibody-based assays for serological
testing of pigs is mandatory. For this purpose, PLHV struc-
tural genes are being cloned and expressed.
The identification and initial biological characterization
of the third porcine gammaherpesvirus species, PLHV-3, is
a further important step in exploring the herpesvirus species
infecting pigs for the benefit of safe xenotransplantation.
From all data currently available it can be concluded that the
three PLHV species represent B-cell tropic viruses with a
lymphoproliferative potential. So far only PLHV-1 was
shown experimentally to be associated with porcine lym-
phoproliferative disease. However, due to the close relation-
ship of PLHV-2 and PLHV-3, it can be assumed that these
viruses also cause lymphoproliferative disease under the
same experimental conditions. Analysis of the complete
PLHV genomes and development of a lytic cell culture
system will help to further characterize the porcine lympho-
tropic herpesviruses and to assess their disease potentials in
pig-to-human xenotransplantation.
Methods
Sample collection and DNA preparation
Blood and tissue samples were collected and DNA was
prepared as described previously (Ulrich et al., 1999). Sam-
ples were also collected from experimental pigs housed at
the Bundesforschungsanstalt fu¨r Viruskrankheiten der Tiere
(BFAV) in Tu¨bingen, Germany, the Klinik fu¨r Klauentiere
at the Freie Universita¨t Berlin, Germany, and from feral
pigs hunted in Florida, USA. DNA samples from French,
Italian, and Swedish domestic pigs were kindly provided by
A. Jestin, Dario Di Luca, and Frederik Widen. DNA sam-
ples from miniature swine, kept at the Transplantation Bi-
ology Research Unit (TBRC), Massachusetts General Hos-
pital, Harvard Medical School, Boston, USA, were kindly
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provided by Chris Huang (TBRC) and Clive Patience (Im-
merge Biotherapeutics Inc., Boston, USA).
Amplification of PLHV-3 sequences with PCR
Pan-gammaherpesvirus PCR assays were carried out as
single-round, semi-nested or nested PCR. Primers were de-
generate and/or deoxyinosine substituted and published pre-
viously for ORF 08 (glycoprotein B gene) and ORF 09
(DNA polymerase gene) (Chmielewicz et al., 2001; Ehlers
et al., 1999a). Degenerate primers were also designed for
the gammaherpesvirus ORFs 03, 06, 17, 25, 39, 44, and 46
(primers not listed). PCR mixtures (25 l) contained 1 M
of each primer. All other reaction conditions were as de-
scribed earlier (Ehlers et al., 1999b).
PLHV-3 sequences extending upstream from ORF 03
were amplified by Genexpress GmbH (Berlin) using the
Universal GenomeWalker kit from Clontech Laboratories,
Inc., as described by Ulrich et al. (1999).
For specific amplification of PLHV-3, amplimers of
3–12 kbp length were generated with the Expand-Long-
Template System (Roche Diagnostics, Germany) according
to the manufacturer’s instructions (primers not listed). To
analyze the PLHV-3 prevalence, glycoprotein B and DPOL
sequences were specifically amplified with the primer pairs
905s/905as (product size: 256 bp) and 886s/886as (product
size: 148 bp), respectively, using AmpliTaq Gold (Perkin
Elmer) as published (Ehlers et al., 1999a) (Table 2).
Amplification of PLHV-2 sequences with specific PCR
The high sequence similarity between PLHV-1 and
PLHV-2 DPOL genes (Ulrich et al., 1999) enabled the use
of primers, which had been already used for specific am-
plification of PLHV-1 DNA (Goltz et al., 2002), for ampli-
fication of PLHV-2 DNA. Approximately 75% of the region
between ORF 03 and ORF 46 could be amplified. Remain-
ing gaps were closed with primers deduced from the newly
determined PLHV-2 sequences. The 5-part of PLHV-2
ORF 03 was amplified as described above for ORF 03 of
PLHV-3.
Cloning of glycoprotein B sequences
For standardization of real-time PCR assays, amplimers
of partial glycoprotein B sequences of PLHV-1, -2, and -3
were cloned into the vector pCR 2.1 TOPO according to the
manufacturer’s instructions (TOPO TA cloning kit, Invitro-
gen).
Real-time PCR (TaqMan) for PLHV-1, PLHV-2, and
PLHV-3
Real-time PCR was performed using primers and probes
specific for the glycoprotein B gene of PLHV-1, PLHV-2,
and PLHV-3 and the porcine -actin gene respectively
(Table 2). PCR contained 300 nM of both sense and anti-
sense primers, except for the sense primer for PLHV-3 (900
nM) and the sense primer for -actin (100 nM). All probes
were used in a concentration of 100 nM. The reaction
mixtures contained the TaqMan Universal PCR Master Mix
(Applied Biosystems) at a 50% lower concentration as sug-
gested by the manufacturer. The reaction was performed in
an ABI PRISM 7700 Sequence Detection System (Perkin
Elmer) as follows: 2 min at 50°C (AmpErase reaction) and
10 min at 95°C (denaturation) were followed by 45 cycles
at 95°C for 20 s and annealing/extension at 55°C (PLHV-1,
-2, -3) or 67°C (-actin) for 1 min. All samples were tested
in triplicate; from the three resulting Ct values the median
was used for further calculations. Standard curves were
generated using 101 to 106 copies of the plasmids containing
the PLHV target sequences. For all three viruses the detec-
tion limit was determined to be 20 copies; 10 copies could
be detected in 5 of 6 PCRs. Cross-reactivity of the PCR
systems between the three PLH viruses as well as with
porcine genomic DNA was also tested. No cross-reactions
were observed, neither with genomic DNA nor with up to
106 copies of the plasmids.
Sequence analysis, ORF designation, and phylogenetic
tree construction
PCR product purification and direct sequencing with dye
terminator chemistry as well as nucleotide and amino acid
sequence analysis were performed as described (Goltz et al.,
2002). The following criteria were chosen for the ORF
analysis: (i) presence of a typical translational start and stop
signal, (ii) a minimal length of more than 60 amino acids,
(iii) the longer of two overlapping ORFs is significant, and
(iv) ORFs are conserved in other herpesviruses or found in
at least two different PCR isolates of a PLHV species. The
orientation of the analyzed genome stretch and the nomen-
clature of ORFs were adapted to those of HVS and other
rhadinoviruses (Albrecht et al., 1992). The ORFs unique to
PLHV-3 (P3.1 to P3.4) or PLHV-2 (P2.1), which had no
homologs in databases, were only preliminarily designated.
Redesignation may be necessary after possible detection of
additional unique ORFs between the ORFs 03 and the left
ends of the genomes. Multiple sequence alignments and
phylogenetic tree construction with neighbor-joining and
parsimonial analysis were performed as reported by Zim-
mermann et al. (2001).
Abbreviations and nucleotide sequence accession numbers
The PLHV-3 and PLHV-2 sequences determined in
this study were deposited in the GenBank nucleotide
sequence database (PLHV-3 from sample no. 1412,
25457 bp, Accession No. AY170315; PLHV-3 from sample
no. 489, 60326 bp, Accession No.AY170316; PLHV-2 from
sample no. 546, 32480 bp, Accession No. AY170314; PLHV-3
from sample no. 568, 59673 bp, Accession No. AY170317).
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Abbreviations and accession numbers for the sequences
used in Table 1 and Fig. 2 are AIHV-1 (alcelaphine herpes-
virus 1) (complete genome [cg], Accession No. AF005370);
BoHV-4 (bovine herpesvirus 4) (cg, Accession No.
AF318573); CalHV-3 (callithrichine herpesvirus 3) (cg, Ac-
cession No. AF319782); CeHV-15 (cercopithecine herpes-
virus 15  rhesus monkey lymphocryptovirus) (cg, Acces-
sion No. X00784); EBV (Epstein-Barr virus) (cg, Accession
No. AY037858); EHV-2 (equine herpesvirus 2) (cg, Acces-
sion No. U20824); HHV-8 (human herpesvirus 8) (cg, Ac-
cession No. U75698); HVS (herpesvirus saimiri or saimiri-
ine herpesvirus 2 [SaHV-2]) (cg, Accession No. X64346);
HVA (herpesvirus ateles or ateline herpesvirus 3 [AtHV-3])
(cg, Accession No. AF083424); MHV-68 (murine gamma-
herpesvirus 68) (cg, Accession No. U97553); PLHV-1 (por-
cine lymphotropic herpesvirus 1) (partial genome, Acces-
sion No. AF478169); RRV (rhesus monkey rhadinovirus)
(cg, Accession No. AF029302). DPOL and gB sequences:
BLHV (bovine lymphotropic herpesvirus) (DPOL, Acces-
sion No. AF327830; gB, Accession No. AF327832);
CprHV-2 (caprine herpesvirus 2) (gB and DPOL, Accession
No. AF283477); OvHV-2 (ovine herpesvirus 2) (DPOL,
Accession No. AF327831; gB, Accession No. AF327833).
Purification of B-, T-, and myeloid cells from porcine
blood
Blood samples were collected in EDTA-coated tubes.
Peripheral blood mononuclear cells (PBMC) were isolated
by density centrifugation on Ficoll-Paque (Pharmacia).
Cells were washed three times in PBS containing 1% fetal
calf serum. Remaining red blood cells were lysed with 155
mM ammonium chloride, 10 mM potassium hydrogencar-
bonate and 1 mM EDTA, diluted 1:1 with PBS, for 20 min
at 4°C after the first washing step. B-cells, T-cells, and
myeloid cells were purified by magnetic separation (MACS,
Miltenyi BiotecCells). Cells (5107 to 5108) were incu-
bated with 300 ng goat gammaglobulin on a rotating wheel
at 4°C for 20 min to block unspecific binding of the anti-
bodies used for the purification of the subpopulations.
Mouse-anti-immunoglobulin (diluted 1:20; Biermann, Ger-
many), mouse-anti-CD3 (0.1 g/106 cells; Southern Bio-
technologies, USA), or mouse-anti-SWC3 (diluted 1:50;
kindly provided by A. Saalmu¨ller, BFAV Tu¨bingen) were
added at 4°C for 30 min for selection of B-cells, T-cells, or
myeloid cells, respectively. Unbound antibody was re-
moved by washing twice in ice-cold PBS/1% fetal calf
serum. Goat anti-mouse IgG Microbeads (Miltenyi Biotec)
were then added at 4°C for 30 min. The cells were washed
twice and applied to the MACS columns according to the
manufacturer’s instructions.
To determine the purity of the PBMC subpopulations,
they were incubated with a FITC-labeled goat anti-mouse
IgG antibody (diluted 1:250; Jackson ImmunoResearch),
washed, and examined by flow cytometry (FACSCalibur,
Becton Dickinson) after counterstaining with propidium io-
dide. For further analyses, only cell preparations of pigs
were used in which all three subpopulations had a purity of
at least 95%.
Real-time PCR analysis of purified PBMC subpopulations
For every pig four samples were examined (unsorted
PBMC, Ig-cells, CD3-cells, SWC3-cells). For subse-
quent standardization of the four samples, these were tested
in the -actin assay first. The sample with the lowest Ct
value (i.e., containing the highest amount of DNA and the
lowest amount of PCR inhibitors) was chosen to calculate
the difference to the other three Ct values (	Ct). These
differences were then used for correcting the results of the
PLHV assays. Based on the theory that the copy number of
an amplimer doubles with every cycle during the run, the
multiplication of the copy number indicated by the thermal
cycler with 2	Ct gives the copy number which is leveled to
the sample with the lowest Ct value.
Cell lines
The porcine B-cell line L23 was obtained from the Eu-
ropean Collection of Cell Cultures (ECACC), Salisbury,
UK, and maintained according to the supplied instructions.
The EBV-positive cell line B95-8 and the human T-cell line
Molt 4 were kindly provided by K. Borchers and K. Rokos,
respectively, and both maintained in RPMI 1640/10% FCS.
Gardella gel electrophoresis, Southern blotting, and
hybridization
Gardella gel electrophoresis was performed as described
(Gardella et al., 1984). After the gel run, the DNA was
depurinated with 0.25 N HCl, denatured with 0.5 N NaOH/
1.5 M NaCl, transferred by vacuum blotting to a positively
charged nylon membrane in the presence of 1 M ammonium
acetate, and crosslinked. Hybridization was performed us-
ing digoxigenin-labeled probes. Unbound probe was re-
moved with the Roche DIG Wash and Block Buffer Set
according to the manufacturer’s instructions. CDP-Star was
used as a substrate and chemiluminescence was visualized
by exposing the membrane to Lumifilm (Roche).
Generation of hybridization probes
For EBV detection, two probes were generated (PCR
DIG Probe Synthesis Kit, Roche) from the gB and the
DPOL gene, using purified viral DNA. For PLHV-3 detec-
tion, two cloned PCR products of the gB gene served as
templates for DIG probe synthesis. Furthermore, two
(semi-) nested PCR products were generated, spanning the
ORFs 03–06 (3.7 kbp) and ORFs 21–23 (3.2 kbp). They
were purified after agarose gel electrophoresis (Eppendorf
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PerfectPrep Gel Cleanup) and labeled by random priming
(DIG-High Prime, Roche). The PCR-generated probes were
purified using Microspin S-400 HR columns (Pharmacia,
Sweden). For annealing all probes were used in a total
concentration of about 10 ng/ml hybridization solution.
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